Sutton Place Investors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$785K Sell
6,109
-6
-0.1% -$702 0.38% 66
2026
Q1
$736K Buy
6,115
+61
+1% +$7.04K 0.4% 64
2025
Q4
$637K Buy
6,054
+728
+14% +$68.3K 0.35% 64
2025
Q3
$447K Sell
5,326
-383
-7% -$31.5K 0.25% 78
2025
Q2
$452K Buy
+5,709
New +$454K 0.27% 74
2025
Q1
Sell
-17,530
Closed -$1.74M 128
2024
Q4
$1.74M Sell
17,530
-73
-0.4% -$7.53K 1.01% 32
2024
Q3
$2M Buy
17,603
+160
+0.9% +$19K 1.22% 24
2024
Q2
$2.16M Sell
17,443
-17,889
-51% -$2.3M 1.44% 16
2024
Q1
$4.66M Buy
35,332
+15,804
+81% +$1.95M 2.31% 8
2023
Q4
$2.13M Buy
+19,528
New +$2.03M 1.54% 14

Other funds holding MRK

Sutton Place Investors's MRK Position: Q2 2026 in Review

Sutton Place Investors reduced its Merck (MRK) stake by 0.1% in Q2 2026, selling an estimated $702 and leaving 6,109 shares worth $785K. The position accounts for 0.38% of the portfolio, ranked #66.

Sutton Place Investors first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.66M in Q1 2024. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sutton Place Investors held 6,109 shares of Merck worth $785K as of Q2 2026.
  • Sutton Place Investors sold 6 Merck shares in Q2 2026, an estimated $702.
  • Merck made up 0.38% of Sutton Place Investors's portfolio in Q2 2026, its #66 holding.
  • Sutton Place Investors first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • Sutton Place Investors's Merck position peaked at $4.66M in Q1 2024.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sutton Place Investors's 13F filing for Q2 2026, filed 6 Aug 2026.